View in EDS HTML Full Text PDF Full Text

Daratumumab, cyclophosphamide, bortezomib, and dexamethasone for multiple myeloma: final results of the LYRA study.

Saved in:
Bibliographic Details
Title: Daratumumab, cyclophosphamide, bortezomib, and dexamethasone for multiple myeloma: final results of the LYRA study.
Authors: Yimer H; Texas Oncology, Tyler/US Oncology Research, Tyler, TX, USA., Melear J; Texas Oncology, Austin, TX, USA., Faber E; Oncology Hematology Care, Inc, Cincinnati, OH, USA., Bensinger WI; Swedish Cancer Institute, Seattle, WA, USA., Burke JM; US Oncology Research, Rocky Mountain Cancer Centers, Aurora, CO, USA., Narang M; US Oncology Research, Maryland Oncology Hematology, Columbia, MD, USA., Stevens D; Norton Health Care, Louisville, KY, USA., Gray KS; Janssen Scientific Affairs, LLC, Horsham, PA, USA., Lutska Y; Janssen Scientific Affairs, LLC, Horsham, PA, USA., Bobba P; Janssen Scientific Affairs, LLC, Horsham, PA, USA., Qi K; Janssen Research & Development, LLC, Titusville, NJ, USA., Hoehn D; Janssen Scientific Affairs, LLC, Horsham, PA, USA., Qi M; Janssen Research & Development, LLC, Spring House, PA, USA., Lin TS; Janssen Scientific Affairs, LLC, Horsham, PA, USA., Rifkin RM; US Oncology Research, Rocky Mountain Cancer Centers, Denver, CO, USA.
Source: Leukemia & lymphoma [Leuk Lymphoma] 2022 Oct; Vol. 63 (10), pp. 2383-2392. Date of Electronic Publication: 2022 Jun 22.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35730586
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Daratumumab, cyclophosphamide, bortezomib, and dexamethasone for multiple myeloma: final results of the LYRA study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Yimer+H%22">Yimer H</searchLink>; Texas Oncology, Tyler/US Oncology Research, Tyler, TX, USA.<br /><searchLink fieldCode="AU" term="%22Melear+J%22">Melear J</searchLink>; Texas Oncology, Austin, TX, USA.<br /><searchLink fieldCode="AU" term="%22Faber+E%22">Faber E</searchLink>; Oncology Hematology Care, Inc, Cincinnati, OH, USA.<br /><searchLink fieldCode="AU" term="%22Bensinger+WI%22">Bensinger WI</searchLink>; Swedish Cancer Institute, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Burke+JM%22">Burke JM</searchLink>; US Oncology Research, Rocky Mountain Cancer Centers, Aurora, CO, USA.<br /><searchLink fieldCode="AU" term="%22Narang+M%22">Narang M</searchLink>; US Oncology Research, Maryland Oncology Hematology, Columbia, MD, USA.<br /><searchLink fieldCode="AU" term="%22Stevens+D%22">Stevens D</searchLink>; Norton Health Care, Louisville, KY, USA.<br /><searchLink fieldCode="AU" term="%22Gray+KS%22">Gray KS</searchLink>; Janssen Scientific Affairs, LLC, Horsham, PA, USA.<br /><searchLink fieldCode="AU" term="%22Lutska+Y%22">Lutska Y</searchLink>; Janssen Scientific Affairs, LLC, Horsham, PA, USA.<br /><searchLink fieldCode="AU" term="%22Bobba+P%22">Bobba P</searchLink>; Janssen Scientific Affairs, LLC, Horsham, PA, USA.<br /><searchLink fieldCode="AU" term="%22Qi+K%22">Qi K</searchLink>; Janssen Research & Development, LLC, Titusville, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Hoehn+D%22">Hoehn D</searchLink>; Janssen Scientific Affairs, LLC, Horsham, PA, USA.<br /><searchLink fieldCode="AU" term="%22Qi+M%22">Qi M</searchLink>; Janssen Research & Development, LLC, Spring House, PA, USA.<br /><searchLink fieldCode="AU" term="%22Lin+TS%22">Lin TS</searchLink>; Janssen Scientific Affairs, LLC, Horsham, PA, USA.<br /><searchLink fieldCode="AU" term="%22Rifkin+RM%22">Rifkin RM</searchLink>; US Oncology Research, Rocky Mountain Cancer Centers, Denver, CO, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229007422%22">Leukemia & lymphoma</searchLink> [Leuk Lymphoma] 2022 Oct; Vol. 63 (10), pp. 2383-2392. <i>Date of Electronic Publication: </i>2022 Jun 22.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9007422 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1029-2403 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210268022%22">10268022 </searchLink><i>NLM ISO Abbreviation: </i>Leuk Lymphoma <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35730586
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1080/10428194.2022.2076847
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2383
    Titles:
      – TitleFull: Daratumumab, cyclophosphamide, bortezomib, and dexamethasone for multiple myeloma: final results of the LYRA study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Yimer H
      – PersonEntity:
          Name:
            NameFull: Melear J
      – PersonEntity:
          Name:
            NameFull: Faber E
      – PersonEntity:
          Name:
            NameFull: Bensinger WI
      – PersonEntity:
          Name:
            NameFull: Burke JM
      – PersonEntity:
          Name:
            NameFull: Narang M
      – PersonEntity:
          Name:
            NameFull: Stevens D
      – PersonEntity:
          Name:
            NameFull: Gray KS
      – PersonEntity:
          Name:
            NameFull: Lutska Y
      – PersonEntity:
          Name:
            NameFull: Bobba P
      – PersonEntity:
          Name:
            NameFull: Qi K
      – PersonEntity:
          Name:
            NameFull: Hoehn D
      – PersonEntity:
          Name:
            NameFull: Qi M
      – PersonEntity:
          Name:
            NameFull: Lin TS
      – PersonEntity:
          Name:
            NameFull: Rifkin RM
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 10
              Text: 2022 Oct
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 1029-2403
          Numbering:
            – Type: volume
              Value: 63
            – Type: issue
              Value: 10
          Titles:
            – TitleFull: Leukemia & lymphoma
              Type: main
ResultId 1